Anaemia, Megaloblastic
Description General measures Medicine treatment D51.0-2/D51.2/D51.8-9/D52.0-1/D52.8-9/D53.1/D53.8-9 DESCRIPTION Anaemia caused by a deficiency of folate and/or vitamin B 12 . Note that several medicines can cause macrocytic anaemia (e.g. hydroxyurea, methotrexate, zidovudine, azathioprine, valproic acid, and phenytoin) without deficiencies of folate and/or vitamin B 12 . Clinical manifestations o
D51.0-2/D51.2/D51.8-9/D52.0-1/D52.8-9/D53.1/D53.8-9
DESCRIPTION
- Anaemia caused by a deficiency of folate and/or vitamin B12.
- Note that several medicines can cause macrocytic anaemia (e.g. hydroxyurea, methotrexate, zidovudine, azathioprine, valproic acid, and phenytoin) without deficiencies of folate and/or vitamin B12.
- Clinical manifestations of vitamin B12 deficiency are mainly neurological – peripheral neuropathy, dementia and subacute combined degeneration of the spinal cord.
Investigations
- Elevated MCV (>100 fl) and MCH (>34 pg).
- Pancytopaenia in severe cases.
- FBC and peripheral smear: oval macrocytes, hypersegmentation of neutrophils, thrombocytopenia with giant platelets.
- Decreased serum vitamin B12 and/or red blood cell folate.
- Intrinsic factor antibodies, and/ or anti-parietal cell antibodies are found in pernicious anaemia.
GENERAL MEASURES
- Counsel on dietary modifications to ensure adequate intake of folate and vitamin B12 (especially important in vegetarians and malnourished patients).
- Identify and treat the underlying cause, e.g. antibiotics for bacterial intestinal overgrowth.
- Chronic metformin use can lead to vitamin B12 deficiency by interfering with absorption. Maintain a low threshold for clinical features of vitamin B12 deficiency in patients on metformin, and check serum levels if clinically indicated.
MEDICINE TREATMENT
- Start with folic acid and vitamin B12 supplementation after taking blood samples for RBC folate and serum vitamin B12 levels.
- Monitor serum potassium and replace if necessary.
- Adjust management according to results.
CAUTION
Give vitamin B12 and folic acid together until the test results are available, as giving folic acid alone in patients with a vitamin B12 deficiency may precipitate a permanent neurological deficit.
Folic acid deficiency
- Folic acid, oral, 5 mg daily until Hb returns to normal (see reference ranges in Anaemia).
Note:
Prolonged treatment may be required for malabsorption states.
Vitamin B12 deficiency
For uncomplicated pernicious anemia:
- Vitamin B12, IM, 1 mg on alternate days for 1–2 weeks.
- Followed by 1 mg weekly until blood count is normal.
- Lifelong maintenance dose: 1 mg monthly.
For serious complications from deficiency:
- Vitamin B12 IM, 1 mg daily for 1 week.
- Followed by 1 mg weekly for 1 month.
- Lifelong maintenance dose: 1 mg monthly.
LoE:IVbviii
- Response to treatment is associated with an increase in energy, strength and improvement in sense of well-being.
- Reticulocytosis begins 3–5 days after therapy and peaks at about day 7.
- Anaemia normally corrects within 1–2 months. The white cell count and platelets normalise in 7–10 days. As there is an increase in red blood cell production, iron and folic acid supplementation is also recommended until Hb has normalised.
- Monitor for hypokalaemia in the first few days of therapy (See: Hypokalaemia for management).
Consider the following in the event of response failure:
- Co-existing folate and/or iron deficiency,
- Other causes of macrocytosis:
- Myelodysplasia,
- Hypothyroidism,
- Chronic alcohol use, - Drug-induced, e.g. hydroxyurea, methotrexate, zidovudine, azathioprine, valproic acid and phenytoin.
Prophylaxis:
O99.0/Z49.1/Z29.2
Vitamin B12 prophylaxis:
Vitamin B12 is indicated for patients after total gastrectomy or ileal resection:
- Vitamin B12, IM, 1 mg every second month for life.
Folic acid prophylaxis:
Indications:
- Chronic inherited or acquired haemolytic anaemias, e.g. sickle cell anaemia, thalassaemia
- Myeloproliferative disorders
- Exfoliative skin disorders
- Increased demands, e.g. pregnancy, chronic haemodialysis
- Folic acid, oral, 5 mg daily.
Standard Treatment Guidelines And Essential Medicines List For South Africa, Adult Hospital level_Version 1_30 March 2026
Chapter 2: Blood and Blood Forming Organs; 2.1.2 Anaemia, Megaloblastic
Drugs mentioned
ICD-10 codes
- D51.0Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
- D51.1Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
- D51.2Transcobalamin II deficiency
- D51.8Other vitamin B12 deficiency anaemias
- D51.9Vitamin B12 deficiency anaemia, unspecified
- D52.0Dietary folate deficiency anaemia
- D52.1Drug-induced folate deficiency anaemia
- D52.8Other folate deficiency anaemias
- D52.9Folate deficiency anaemia, unspecified
- D53.1Other megaloblastic anaemias, not elsewhere classified
- D53.8Other specified nutritional anaemias
- D53.9Nutritional anaemia, unspecified
- O99.0Anaemia complicating pregnancy, childbirth and the puerperium
- Z29.2Other prophylactic chemotherapy
- Z49.1Extracorporeal dialysis